Real-World Experience With Dupilumab in Severe Asthma: The Spanish Multicenter Study DUPImpact

20260 citationsJournal Articlediamond Open Access

Authors

Hemily Izaguirre-Flores · Universidad de La Laguna

Ebymar Arismendi · Instituto de Salud Carlos III

Elena Martín-Ruiz de la Rosa · Hospital Universitario Nuestra Señora de Candelaria

Berta Román-Bernal · Hospital Doctor José Molina Orosa

Irene De Lorenzo-García · Hospital Universitario Nuestra Señora de Candelaria

Inmaculada Plasencia-García · Hospital Universitario Nuestra Señora de Candelaria

Abstract

The DUPImpact study confirms the real-world effectiveness of dupilumab in reducing exacerbations and OCS use and improving asthma control and lung function. FEOS and EXACTO enable a multidimensional assessment beyond individual measures.

Topics & Keywords

Asthma and respiratory diseases Dermatology and Skin Diseases Cancer Immunotherapy and Biomarkers

Publication Details

Published in: Journal of Investigational Allergology and Clinical Immunology

Volume 37, Issue 2, pp. 0-0

DOI: 10.18176/jiaci.1156

Field-Weighted Citation Impact: 0.00

Command Palette

Real-World Experience With Dupilumab in Severe Asthma: The Spanish Multicenter Study DUPImpact

Authors

Abstract

Topics & Keywords

Publication Details